I am/have/had
I am looking for
Advanced Filters
Found 71 clinical trials
Improved Assessment of Response in Metastatic Renal Cell Carcinoma Using Spectral-CT
The incidence of renal cancer in Denmark is approximately 900 new cases per year. Untreated, the 5-year survival rate for metastatic renal cancer (mRCC) is 2%. Development of angiogenesis inhibitors (AI) and check-point immunotherapy (CPI) has improved survival. Treatment efficacy is evaluated by CT scans, using RESIST 1.1 (Response Evaluation …
- 4 views
- 12 Feb, 2022
- 1 location